DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2003
| DUOPHARMA BIOTECH BHD |
|
Quarterly report for the financial period ended | 31/12/2003 |
| Quarter | 4 |
| Financial Year End | 31/12/2003 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2003 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2003 | 31/12/2002 | 31/12/2003 | 31/12/2002 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 15,994 | 15,466 | 73,833 | 43,126 |
| 2 | Profit/(loss) before tax | 6,289 | 4,926 | 24,220 | 12,961 |
| 3 | Profit/(loss) after tax and minority interest | 4,478 | 3,655 | 17,720 | 9,565 |
| 4 | Net profit/(loss) for the period | 4,478 | 3,655 | 17,720 | 9,565 |
| 5 | Basic earnings/(loss) per share (sen) | 7.46 | 6.09 | 29.53 | 15.94 |
| 6 | Dividend per share (sen) | 8.00 | 8.00 | 13.00 | 8.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 1.4500 | 1.5000 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| The results of the Group is consolidated from the date of acquisition of Duopharma (M) Sendirian Berhad ("DMSB"). Accordingly, the Group's income statement for the year ended 31 December 2002 would only reflect the 8 months apportionment results of DMSB. The proforma twelve (12) months results of the Group for year ended 31 December 2002 is reflected in the note B1 to the interim financial statements. |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BHD |
| Stock Name | DBIOTEC |
| Date Announced | 26 Feb 2004 |
| Category | Financial Results |
| Reference No | CS-040225-64784 |